Skip to main content
Biotika A.S. logo

Biotika A.S. — Investor Relations & Filings

Ticker · BSL ISIN · SK1120004009 LEI · 097900BGMP0000060091 BSSE Manufacturing
Filings indexed 56 across all filing types
Latest filing 2014-12-10 Interim / Quarterly Rep…
Country SK Slovakia
Listing BSSE BSL

Biotika A.S. is a biotechnology company that manufactures Active Pharmaceutical Ingredients (APIs) for human and veterinary applications. With a history of over 70 years, the company specializes in the biotechnological production of APIs, with its primary products being penicillin and polymyxin B sulfate. Biotika also offers contract manufacturing services, including the transfer and scaling of products from laboratory to commercial production. Additionally, the company engages in research and development activities within the field of biotechnology.

Recent filings

Filing Released Lang Actions
Polročná finančná správa Biotika a.s. 2014
Interim / Quarterly Report Classification · 100% confidence The document is a 'Polročná finančná správa' (Semi-annual financial report) for Biotika, a.s. for the first half of 2014. It contains detailed financial performance data, management commentary, operational updates, and risk management disclosures as required by Slovak law for interim reporting. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2014
2014-12-10 Slovak
Uznesenia z MVZ Biotika a.s. zo dňa 29.9.2014
AGM Information Classification · 98% confidence The document text is in Slovak and discusses resolutions ('Uznesenie') passed during an Extraordinary General Meeting ('Mimoriadne Valné Zhromaždenie' - MVZ). Key topics include approving meeting officials, creating a special reserve fund, and approving a reduction of the share capital ('zníženie základného imania') due to the cancellation of own shares. These actions (approving resolutions, capital changes) are central to shareholder meetings. Since the document details the specific outcomes and resolutions of a General Meeting, it aligns best with the 'AGM Information' category, which covers presentations and materials shared during the Annual General Meeting (AGM), which extends to Extraordinary General Meetings (EGM) materials detailing approved resolutions.
2014-10-03 Slovak
Oznámenie o konaní MVZ
AGM Information Classification · 99% confidence The document text is a formal notice in Slovak calling for an 'mimoriadne valné zhromaždenie' (Extraordinary General Meeting) of the company Biotika a.s. It details the date (4.8.2014), time, location, agenda items (including 'Schválenie nadobudnutia vlastných akcií spoločnosťou' - Approval of the acquisition of own shares), shareholder rights, and registration procedures. This content directly relates to the organization and announcement of a shareholder meeting, which aligns perfectly with the definition of 'AGM Information' (AGM-R), even though it is an Extraordinary General Meeting (EGM) rather than a standard Annual General Meeting (AGM). The key elements are the meeting call and the agenda.
2014-07-03 Slovak
Oznámenie o konaní RVZ
Earnings Release Classification · 99% confidence The document text contains detailed reporting on labor negotiations (wage increases, collective bargaining agreements) for PPS Group, and a separate, detailed report on the bankruptcy and restructuring proceedings (konkurz) of another company, Kopast, including legal disputes between the company, the administrator, and creditors. It also includes comparative financial figures (k 31 12 2013 vs k 31 12 2012) related to the Kopast case. This content strongly suggests a comprehensive business or financial news report covering corporate distress, legal proceedings, and labor disputes, rather than a formal regulatory filing like a 10-K, ER, or IR. Since it details significant legal/restructuring events and is presented as news analysis, it fits best under Legal Proceedings Report (LTR) due to the focus on the Kopast bankruptcy and court disputes, or potentially Regulatory Filings (RNS) as a general news item about corporate events. Given the depth of the legal/restructuring narrative concerning Kopast, LTR is the most specific fit for that major section. The first part is about labor disputes, which can also be related to legal/regulatory matters. Since the document is a news article discussing ongoing legal/restructuring matters and labor disputes, LTR is the most appropriate classification for the significant legal content. FY 2013
2014-04-02 Slovak
Audítovaná Ročná účtovná závierka za rok 2013
Regulatory Filings
2014-03-07 Slovak
Doplnenie k polročnej finančnej správe 2013
Management Reports Classification · 99% confidence The document is titled "VYHLÁSENIE PREDSTAVENSTVA SPOLOČNOSTI" (Statement of the Company's Board) and explicitly refers to the "polročnej finančnej správy spoločnosti Biotika a.s. k 30. júnu 2013" (half-year financial report of Biotika a.s. as of June 30, 2013). This content, which is a formal declaration by management regarding the accuracy of a periodic financial report covering a period shorter than a year, strongly indicates an Interim/Quarterly Report (IR). Although it is a declaration *about* the report, in many regulatory contexts, the management certification/statement is filed concurrently with or as part of the comprehensive interim report package. Given the specific reference to the 'half-year financial report' and the content being the required management assertion for that report, 'IR' (Interim / Quarterly Report) is the most appropriate classification over a general 'RPA' or 'RNS', as it contains substantive content related to the interim reporting period's integrity.
2013-10-18 Slovak

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.